Strata Critical Medical Income Statement (2019-2026) | SRTA

Income Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
12.95M20.32M26.63M35.63M45.27M60.99M71.44M47.48M51.51M67.94M36.06M36.39M35.95M70.80M49.30M66.79M67.38M
Cost of Revenue (Quarter)
9.98M1.23M1.80M30.52M38.11M50.62M55.86M175.03M2.13M51.59M28.55M116.20M28.89M1.63M37.68M154.92M53.27M
Gross Profit (Quarter)
2.98M19.09M24.83M5.11M7.16M10.37M15.58M-127.56M49.39M16.35M7.51M-79.81M7.05M69.17M11.61M-88.13M14.12M
Operating items
Amortization - Intangibles (Quarter)
0.41M1.49M
Research & Development (Quarter)
0.32M0.84M0.83M1.06M1.12M1.44M1.08M0.99M0.67M0.97M0.42M2.15M0.81M0.92M0.45M
Selling, General & Administrative (Quarter)
9.81M12.12M13.98M12.14M16.26M18.41M19.27M41.24M17.21M25.14M13.87M11.72M12.33M20.14M16.30M17.92M15.61M
Other Operating Expenses (Quarter)
10.59M17.09M-23.51M-21.31M40.72M53.35M58.55M40.88M43.50M53.99M28.87M-88.81M-0.40M54.70M38.17M-100.74M1.49M
Operating Expenses (Quarter)
20.72M30.05M-8.70M-8.10M58.10M73.20M78.89M83.11M61.38M80.09M43.15M-74.94M12.74M75.75M54.92M-82.82M17.09M
Operating Income (Quarter)
-7.77M-9.73M-13.69M-9.73M-12.83M-12.21M-7.45M-35.63M-9.87M-12.15M-7.09M-5.90M-5.68M-4.95M-5.62M-6.41M-2.97M
EBIT (Quarter)
-7.77M-9.73M-13.69M-9.73M-12.83M-12.21M-7.45M-35.63M-9.87M-12.15M-7.09M-5.90M-5.68M-4.95M-5.62M-6.41M-2.97M
Non-operating items
Non Operating Investment Income (Quarter)
-0.14M
Interest & Investment Income (Quarter)
2.08M2.15M2.26M2.07M1.79M1.76M1.59M1.32M1.16M1.13M0.64M0.47M
Non Operating Income (Quarter)
-16.52M-3.10M2.68M18.14M2.44M-0.40M7.87M0.67M5.55M0.88M1.47M-1.53M4.07M1.23M-4.04M1.02M5.38M
Net income details
EBT (Quarter)
-7.77M-12.83M-11.01M8.41M-10.39M-12.61M0.42M-34.96M-4.32M-11.27M-5.63M-7.43M-1.61M-3.72M-9.66M-5.39M2.40M
Tax Provisions (Quarter)
-3.64M-0.20M-0.38M0.13M-1.02M-0.08M0.05M0.02M
Profit After Tax (Quarter)
-24.29M-9.18M-11.01M8.41M-27.26M-10.19M-12.23M0.29M-33.94M-4.23M-11.33M-1.95M-7.43M-3.49M-3.74M57.42M56.02M2.40M
Income from Continuing Operations (Quarter)
-7.77M-9.18M-11.01M8.41M-10.19M-12.23M0.29M-33.94M-4.23M-11.33M-5.63M-7.43M-1.61M-3.74M-9.66M-5.39M2.40M
Consolidated Net Income (Quarter)
-7.77M-9.18M-11.01M8.41M-10.19M-12.23M0.29M-33.94M-4.23M-11.33M3.67M-2.36M-1.88M-3.74M67.07M-3.44M-0.25M
Income towards Parent Company (Quarter)
-7.77M-9.18M-11.01M8.41M-10.19M-12.23M0.29M-33.94M-4.23M-11.33M3.67M-2.36M-1.88M-3.74M67.07M-3.44M-0.25M
Net Income towards Common Stockholders (Quarter)
-7.77M-9.18M-11.01M8.41M-10.19M-12.23M0.29M-33.94M-4.23M-11.33M3.67M-2.36M-1.88M-3.74M67.07M-3.44M-0.25M
Additional items
EPS (Basic) (Quarter)
-0.47-0.13-0.160.11-0.14-0.170.00-0.46-0.06-0.15-0.03-0.24-0.02-0.05-0.120.680.03
EPS (Weighted Average and Diluted) (Quarter)
-0.47-0.13-0.160.10-0.14-0.170.00-0.46-0.06-0.15-0.07-0.12-0.02-0.050.70-0.120.03
Shares Outstanding (Weighted Average) (Quarter)
51.57M42.88M69.76M70.77M70.91M71.10M71.24M71.99M73.17M74.14M73.52M75.80M77.60M78.04M77.50M79.89M81.30M82.45M82.09M85.32M
Shares Outstanding (Diluted Average) (Quarter)
38.55M42.88M77.68M70.77M70.91M71.47M71.24M71.99M73.17M81.01M73.52M75.80M77.60M77.15M77.50M79.89M81.30M81.22M82.09M90.17M
EBITDA (Quarter)
-7.77M-9.73M-13.69M-9.73M-12.83M-12.21M-7.45M-35.63M-9.87M-12.15M-7.09M-5.90M-5.68M-4.95M-5.62M-6.41M-2.97M
Tax Rate (Quarter)
28.40%1.89%2.98%30.86%2.93%1.95%-0.46%-0.56%